
Please try another search
(Reuters) - Efforts by companies to strike merger agreements with buyout firms are floundering in stormy markets, with private equity struggling to raise financing for bids big...
(Reuters) - The U.S. government has ordered an additional 2.5 million doses of Bavarian Nordic's vaccine for use against monkeypox outbreaks, the U.S. Department of Health and...
(Reuters) -French IT consultancy Capgemini reiterated on Friday it has no intention of acquiring or being involved in Atos's assets, stating they were not aligned with the group's...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.